The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Restricting the Selection of Antibiotic‐Resistant Mutants: A General Strategy Derived from Fluoroquinolone Studies
Abstract
Studies with fluoroquinolones have led to a general method for restricting the selection of antibiotic-resistant mutants. The strategy is based on the use of antibiotic concentrations that require cells to obtain 2 concurrent resistance mutations for growth. That concentration has been called the "mutant prevention concentration" (MPC) because no resistant colony is recovered even when >10(10) cells are plated. Resistant mutants are selected exclusively within a concentration range (mutant selection window) that extends from the point where growth inhibition begins, approximated by the minimal inhibitory concentration, up to the MPC. The dimensions of the mutant selection window can be reduced in a variety of ways, including adjustment of antibiotic structure and dosage regimens. The window can be closed to prevent mutant selection through combination therapy with > or =2 antimicrobial agents if their normalized pharmacokinetic profiles superimpose at concentrations that inhibit growth. Application of these principles could drastically restrict the selection of drug-resistant pathogens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DNA gyrase, topoisomerase IV, and the 4-quinolones.
Drlica, K., & Zhao, X. (1997) · Microbiology and molecular biology reviews : MMBR · doi:10.1128/.61.3.377-392.1997 · Cited by 1,494
Self-citationThe Emergence of Drug-Resistant Tuberculosis in New York City
Frieden, T. R., Sterling, T., Pablos-Mendez, A., Kilburn, J. O., Cauthen, G. M., & Dooley, S. W. (1993) · New England Journal of Medicine · doi:10.1056/nejm199302253280801 · Cited by 939
Quinolone-Resistant Campylobacter jejuni Infections in Minnesota, 1992–1998
Smith, K. E., Besser, J. M., Hedberg, C. W., Leano, F. T., Bender, J. B., Wicklund, J. H., Johnson, B. P., Moore, K. A., & Osterholm, M. T. (1999) · New England Journal of Medicine · doi:10.1056/nejm199905203402001 · Cited by 666
Staphylococcus aureus: A Well–Armed Pathogen
Archer, G. L. (1998) · Clinical Infectious Diseases · doi:10.1086/520289 · Cited by 658
Endtz, H. P., Ruijs, G. J., van Klingeren, B., Jansen, W. H., van der Reyden, T., & Mouton, R. P. (1991) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/27.2.199 · Cited by 590
Bifani, P. J. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03530300036037 · Cited by 381
Emergence and Dissemination of Quinolone-Resistant Escherichia coli in the Community
Garau, J., Xercavins, M., Rodríguez-Carballeira, M., Gómez-Vera, J. R., Coll, I., Vidal, D., Llovet, T., & Ruíz-Bremón, A. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.11.2736 · Cited by 337
Mechanism of fluoroquinolone action
Drlica, K. (1999) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(99)00008-9 · Cited by 319
Self-citationBlondeau, J. M., Zhao, X., Hansen, G., & Drlica, K. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.2.433-438.2001 · Cited by 314
Self-citationVernon, A., Burman, W., Benator, D., Khan, A., & Bozeman, L. (1999) · The Lancet · doi:10.1016/s0140-6736(98)11467-8 · Cited by 308
Dong, Y., Zhao, X., Domagala, J., & Drlica, K. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.7.1756 · Cited by 278
Self-citationMultidrug Resistance — A Sign of the Times
Levy, S. B. (1998) · New England Journal of Medicine · doi:10.1056/nejm199805073381909 · Cited by 242
Pan, X. S., & Fisher, L. M. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.2.471 · Cited by 237
DNA topoisomerase targets of the fluoroquinolones: A strategy for avoiding bacterial resistance
Zhao, X., Xu, C., Domagala, J., & Drlica, K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13991 · Cited by 213
Self-citationConcentrations of bacteria in cerebrospinal fluid of patients with bacterial meningitis
Feldman, W. E. (1976) · The Journal of Pediatrics · doi:10.1016/s0022-3476(76)80003-0 · Cited by 212
Development of resistance during antibiotic therapy
Milatovic, D., & Braveny, I. (1987) · European Journal of Clinical Microbiology · doi:10.1007/bf02017607 · Cited by 174
Rastogi, N., Labrousse, V., & Goh, K. S. (1996) · Current Microbiology · doi:10.1007/s002849900095 · Cited by 168
EXAMINATION OF THE ANUS IN SUSPECTED CHILD SEXUAL ABUSE
Roberts, R. I., Wynne, J., & Hobbs, C. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90498-8 · Cited by 165
Zhou, J., Dong, Y., Zhao, X., Lee, S., Amin, A. G., Ramaswamy, S. V., Domagala, J. M., Musser, J. M., & Drlica, K. (2000) · The Journal of Infectious Diseases · doi:10.1086/315708 · Cited by 148
Self-citationReasons for the Emergence of Antibiotic Resistance
Tenover, F. C., & McGowan, J. E. (1996) · The American Journal of the Medical Sciences · doi:10.1016/s0002-9629(15)41625-8 · Cited by 141
Ciprofloxacin resistant Campylobacter spp. in humans: an epidemiological and laboratory study
Gaunt, P. N., & Piddock, L. J. V. (1996) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/37.4.747 · Cited by 130
Dong, Y., Zhao, X., Kreiswirth, B. N., & Drlica, K. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2581-2584.2000 · Cited by 128
Self-citationReasons for the Emergence of Antibiotic Resistance
Tenover, F. C., & McGowan, J. E. (1996) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199601000-00003 · Cited by 118
First-line tuberculosis therapy and drug-resistant Mycobacterium tuberculosis in prisons
Coninx, R., Mathieu, C., Debacker, M., Mirzoev, F., Ismaelov, A., Haller, R. D., & Meddings, D. (1999) · The Lancet · doi:10.1016/s0140-6736(98)08341-x · Cited by 114
Bacterial counts in cerebrospinal fluid of children with meningitis
Bingen, É., Lambert-zechovsky, N., Mariani‐Kurkdjian, P., Doit, C., Aujard, Y., Fournerie, F., & Mathieu, H. (1990) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01968060 · Cited by 109
Strategies to minimize the development of antibiotic resistance.
Baquero, F., & Negri, M. C. (1997) · PubMed · Cited by 95
Fixed-Dose Combinations of Antituberculous Medications To Prevent Drug Resistance
Moulding, T., Dutt, A. K., & Reichman, L. B. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-12-199506150-00010 · Cited by 75
Resistance to Quinolones in Gram-Negative Microorganisms: Mechanisms and Prevention
Baquero, F. (1990) · European Urology · doi:10.1159/000464084 · Cited by 40
Trends in the Susceptibility of Tuberculosis in New York City, 1987-1991
Sepkowitz, K. A., Telzak, E. E., Recalde, S., Armstrong, D., & the New York City Area Tuberculosis Working Group (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/18.5.755 · Cited by 39
The Epidemiology of Bacterial Resistance to Antimicrobial Agents
Tenover, F. C., & McGowan, J. E. (2009) · Springer eBooks · doi:10.1007/978-0-387-09843-2_4 · Cited by 12
Cited by
Microbiological effects of sublethal levels of antibiotics
Andersson, D. I., & Hughes, D. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3270 · Cited by 1,757
Antibacterial free fatty acids: activities, mechanisms of action and biotechnological potential
Desbois, A. P., & Smith, V. J. (2010) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-009-2355-3 · Cited by 1,442
Mechanisms of Resistance to Quinolones
Jacoby, G. A. (2005) · Clinical Infectious Diseases · doi:10.1086/428052 · Cited by 924
Efflux-Mediated Drug Resistance in Bacteria
Li, X.-Z., & Nikaido, H. (2004) · Drugs · doi:10.2165/00003495-200464020-00004 · Cited by 798
Strategies to Minimize Antibiotic Resistance
Lee, C.-R., Cho, I., Jeong, B., & Lee, S. (2013) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph10094274 · Cited by 446
Metadata
- Authors
- Zhao, X., & Drlica, K.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-09-15
- Volume
- 33
- Issue
- s3
- Pages
- S147-S156
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2128160648
- Cited by
- 397
- References
- 30
- FWCI
- 9.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.